Compassionate Use of Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Gastrointestinal Tract

Completed · Not applicable

Conditions studied: Graft Versus Host Disease

In brief

RATIONALE: Beclomethasone may be effective in treating patients who have graft-versus-host disease of the gastrointestinal tract. PURPOSE: Compassionate use of beclomethasone in treating patients who have graft-versus-host disease of the gastrointestinal tract that has not responded to previous therapy.

Key facts

Study ID

NCT00055666

Run by

Roswell Park Cancer Institute

People needed

51

Starts

2001-03-01

Expected to finish

2006-04-01

Last updated by the study team

2011-03-08

Who can join

Age: 4 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Roswell Park Cancer Institute — Buffalo, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.